Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.21 USD | -3.28% | -4.22% | +72.05% |
Financials (USD)
Sales 2024 * | 197M | Sales 2025 * | 218M | Capitalization | 865M |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -52M | EV / Sales 2024 * | 4.33 x |
Net cash position 2024 * | 11.13M | Net cash position 2025 * | 41.33M | EV / Sales 2025 * | 3.77 x |
P/E ratio 2024 * |
-16
x | P/E ratio 2025 * |
-16.7
x | Employees | 474 |
Yield 2024 * |
0.58% | Yield 2025 * |
-
| Free-Float | 95.74% |
Latest transcript on Silk Road Medical, Inc
1 day | +1.86% | ||
1 week | -3.56% | ||
Current month | +12.81% | ||
1 month | +23.20% | ||
3 months | +25.39% | ||
6 months | +165.18% | ||
Current year | +78.73% |
Managers | Title | Age | Since |
---|---|---|---|
Charles McKhann
CEO | Chief Executive Officer | 55 | Nov. 01 |
Lucas Buchanan
DFI | Director of Finance/CFO | 46 | 09-07-31 |
William Whealon
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Don Zurbay
BRD | Director/Board Member | 56 | 18-03-25 |
Kevin Ballinger
BRD | Director/Board Member | 51 | 20-12-02 |
Jack Lasersohn
CHM | Chairman | 70 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 21.1 | -3.81% | 87 717 |
24-05-24 | 21.93 | +1.86% | 385,326 |
24-05-23 | 21.53 | -3.32% | 588,469 |
24-05-22 | 22.27 | +1.04% | 563,941 |
24-05-21 | 22.04 | -3.08% | 556,737 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+78.73% | 865M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.49% | 40.74B | |
+21.98% | 31.6B | |
+16.38% | 25.56B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- SILK Stock